Screener
Sionna Therapeutics SION Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Sionna Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Sionna Therapeutics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033876
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net cash provided by financing activities | 1,893 | 202,389 |
| Net increase in cash, cash equivalents and restricted cash | 4,873 | 44,907 |
| Cash, cash equivalents and restricted cash at beginning of period | 59,414 | 38,750 |
| Cash, cash equivalents and restricted cash at end of period | $64,287 | $83,657 |
| Supplemental disclosure of non-cash investing and financing activities: | ||
| Conversion of convertible preferred stock into common stock upon closing of initial public offering | — | $330,368 |
| Offering costs transferred to additional paid in capital | — | 4,265 |
| Deferred offering costs in accrued expenses and accounts payable | 265 | 318 |
Item 1. Financial Statements
FAQ
- What is Sionna Therapeutics's cash & equivalents?
- Sionna Therapeutics (SION) reported cash & equivalents of $64.29M in Q1 2026.
- How has Sionna Therapeutics's cash & equivalents changed year-over-year?
- Sionna Therapeutics's cash & equivalents decreased by 23.2% year-over-year, from $83.66M to $64.29M.
- What is the long-term trend for Sionna Therapeutics's cash & equivalents?
- Over 2 years (2023 to 2025), Sionna Therapeutics's cash & equivalents has grown at a 22.7% compound annual growth rate (CAGR), from $39.48M to $59.41M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Sionna Therapeutics's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude